Oculis Holding AG (OCS) Other Non-Current Assets (2022 - 2026)
Oculis Holding AG (OCS) recorded quarterly Other Non-Current Assets of $1.0 million in Q1 2026, up 3.5% quarter-over-quarter from $982168.3 in Q4 2025, and up 79.9% on a YoY basis from $565023.3 in Q1 2025.
Oculis Holding AG (OCS) Other Non-Current Assets (2022 - 2026) Analysis & Trends
Oculis Holding AG's Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 79.9% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (up 79.9% YoY), while the FY2025 annual figure was $982168.3, up 80.76% from the prior year.
- Other Non-Current Assets was $1.0 million for Q1 2026 at Oculis Holding AG, up from $982168.3 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.0 million in Q1 2026 to a low of $76813.6 in Q4 2022.
- Historically, Other Non-Current Assets has averaged $411139.4 across 5 years, with a median of $196831.2 in 2024.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets climbed 25.66% in 2024, then soared 466.87% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $76813.6 in 2022, then jumped by 30.62% to $100334.5 in 2023, then surged by 441.55% to $543364.4 in 2024, then soared by 80.76% to $982168.3 in 2025, then increased by 3.5% to $1.0 million in 2026.
- The last three Other Non-Current Assets figures came in at $1.0 million (Q1 2026), $982168.3 (Q4 2025), and $665058.3 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - | 1.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.02 Mn |
| Dec 31, 2025 | 982,168.29 |
| Sep 30, 2025 | 665,058.26 |
| Jun 30, 2025 | 643,805.49 |
| Mar 31, 2025 | 565,023.27 |
| Dec 31, 2024 | 543,364.40 |
| Sep 30, 2024 | 183,518.95 |
| Jun 30, 2024 | 196,831.24 |
| Mar 31, 2024 | 99,674.36 |
| Dec 31, 2023 | 100,334.55 |
| Sep 30, 2023 | 146,047.68 |
| Jun 30, 2023 | 125,675.84 |
| Dec 31, 2022 | 76,813.62 |